Warkany syndrome 1

Warkany syndrome 1 is a rare genetic disorder characterized by a variety of congenital anomalies. It is also known as Trisomy 8 mosaicism syndrome due to the presence of an extra chromosome 8 in some of the body's cells. This condition was first described by the Austrian-American pediatrician Josef Warkany in the mid-20th century.
Presentation[edit]
Individuals with Warkany syndrome 1 often exhibit a range of physical abnormalities and developmental delays. Common features include:
- Distinctive facial features such as a prominent forehead, deep-set eyes, and a broad nasal bridge.
- Musculoskeletal anomalies including joint contractures, scoliosis, and limb abnormalities.
- Intellectual disability, which can vary from mild to severe.
- Congenital heart defects, which may require surgical intervention.
- Urogenital anomalies, such as undescended testes in males or kidney malformations.
Diagnosis[edit]
The diagnosis of Warkany syndrome 1 is typically made through a combination of clinical evaluation and genetic testing. Karyotype analysis can reveal the presence of an extra chromosome 8 in some cells, confirming the diagnosis. Prenatal diagnosis may also be possible through amniocentesis or chorionic villus sampling.
Management[edit]
There is no cure for Warkany syndrome 1, and treatment is primarily supportive and symptomatic. Management strategies may include:
- Surgical correction of congenital anomalies, such as heart defects or limb deformities.
- Physical therapy to address musculoskeletal issues and improve mobility.
- Special education services to support cognitive development and learning.
- Regular monitoring and management of associated health issues, such as kidney function and cardiac health.
Prognosis[edit]
The prognosis for individuals with Warkany syndrome 1 varies widely depending on the severity of the condition and the presence of associated anomalies. With appropriate medical care and supportive therapies, many individuals can lead fulfilling lives, although they may require ongoing medical and educational support.
See also[edit]
References[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
